Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-03-01 Sale |
2022-03-02 7:59 pm |
iTeos Therapeutics Inc. | ITOS | McGrath Yvonne Chief Scientific Officer |
10,000 | $36.76 | $367,570 | 85,123 (Direct) |
View |
| 2021-06-08 Sale |
2021-06-10 5:35 pm |
iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development |
7,927 | $20 | $158,540 | 95,123 (Direct) |
View |
| 2021-05-24 Sale(A) |
2021-06-03 4:19 pm |
iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development |
7,927 | $21.92 | $173,796 | 110,977 (Direct) |
View |
| 2021-06-01 Sale |
2021-06-03 4:17 pm |
iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development |
7,927 | $20.17 | $159,903 | 206,423 (Direct) |
View |
| 2021-05-24 Sale |
2021-05-26 4:09 pm |
iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development |
7,927 | $21.92 | $173,796 | 110,977 (Direct) |
View |
| 2021-05-17 Sale |
2021-05-19 4:14 pm |
iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development |
7,926 | $24.69 | $195,719 | 118,904 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-07 Option Award |
2025-03-11 8:00 pm |
N/A 2035-03-07 |
iTeos Therapeutics Inc. | ITOS | McGrath Yvonne Chief Scientific Officer |
106,300 | $0 | 137,300 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-08 7:58 pm |
N/A 2034-03-07 |
iTeos Therapeutics Inc. | ITOS | McGrath Yvonne Chief Scientific Officer |
153,600 | $0 | 153,600 (Direct) |
View |
| 2023-12-05 Option Award |
2023-12-07 8:22 pm |
N/A N/A |
iTeos Therapeutics Inc. | ITOS | McGrath Yvonne Chief Scientific Officer |
31,000 | $0 | 31,000 (Direct) |
View |
| 2023-03-09 Option Award |
2023-03-10 7:54 pm |
N/A 2033-03-09 |
iTeos Therapeutics Inc. | ITOS | McGrath Yvonne Chief Scientific Officer |
130,000 | $0 | 130,000 (Direct) |
View |
| 2022-03-11 Option Award |
2022-03-14 8:02 pm |
N/A 2032-03-11 |
iTeos Therapeutics Inc. | ITOS | McGrath Yvonne Chief Scientific Officer |
85,000 | $0 | 85,000 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-02 7:59 pm |
N/A 2030-05-01 |
iTeos Therapeutics Inc. | ITOS | McGrath Yvonne Chief Scientific Officer |
10,000 | $0 | 85,123 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-02 7:59 pm |
N/A N/A |
iTeos Therapeutics Inc. | ITOS | McGrath Yvonne Chief Scientific Officer |
10,000 | $4.24 | 85,123 (Direct) |
View |
| 2021-06-08 Exercise |
2021-06-10 5:35 pm |
N/A N/A |
iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development |
7,927 | $4.23 | 95,123 (Direct) |
View |
| 2021-06-08 Exercise |
2021-06-10 5:35 pm |
N/A 2030-05-01 |
iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development |
7,927 | $0 | 95,123 (Direct) |
View |
| 2021-05-24 Exercise(A) |
2021-06-03 4:19 pm |
N/A N/A |
iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development |
7,927 | $4.23 | 110,977 (Direct) |
View |
| 2021-05-24 Exercise(A) |
2021-06-03 4:19 pm |
N/A 2030-05-01 |
iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development |
7,927 | $0 | 110,977 (Direct) |
View |
| 2021-06-01 Exercise |
2021-06-03 4:17 pm |
N/A N/A |
iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development |
7,927 | $4.23 | 206,423 (Direct) |
View |
| 2021-06-01 Exercise |
2021-06-03 4:17 pm |
N/A 2030-05-01 |
iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development |
7,927 | $0 | 206,423 (Direct) |
View |
| 2021-05-24 Exercise |
2021-05-26 4:09 pm |
N/A N/A |
iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development |
7,927 | $4.23 | 110,977 (Direct) |
View |
| 2021-05-24 Exercise |
2021-05-26 4:09 pm |
N/A 2030-05-01 |
iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development |
7,927 | $0 | 110,977 (Direct) |
View |
| 2021-05-17 Exercise |
2021-05-19 4:14 pm |
N/A N/A |
iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development |
7,926 | $4.23 | 118,904 (Direct) |
View |
| 2021-05-17 Exercise |
2021-05-19 4:14 pm |
N/A 2030-05-01 |
iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development |
7,926 | $0 | 118,904 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 4:15 pm |
N/A 2031-03-01 |
iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development |
45,000 | $0 | 45,000 (Direct) |
View |
Ownership |
2020-07-23 7:24 pm |
N/A 2030-05-01 |
iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development |
0 | $0 | 126,830 (Direct) |
View |